rood blauwe elepsis logo Belegger.nl
Uitgebreid zoeken

Sopheon Terug naar discussie overzicht

Sopheon september 2023

14 Posts
| Omlaag ↓
  3. Spectator 10 september 2023 12:56

    • Spectator

      Lid sinds: 21 jul 2022

      Laatste bezoek: 16 dec 2024

    • Aanbevelingen

      Ontvangen: 5

      Gegeven: 0

    •    Aantal posts: 19

    Wie begrijpt wat er aan de hand is? Het lijkt dat het Sopheon voor de wind gaat. Toch loopt de waarde van het aandeel sinds 2018 alleen maar achteruit.
  4. Tritace 12 september 2023 16:53

    • Tritace

      Lid sinds: 21 jan 2022

      Laatste bezoek: 31 jan 2025

    • Aanbevelingen

      Ontvangen: 16

      Gegeven: 14

    •    Aantal posts: 70

    Sopheon customers win three straight Outstanding Corporate Innovator Awards
    Forward-thinking companies have embraced the market trend of InnovationOps to operationalize their innovation efforts, reducing risk and increasing positive outcomes

    PITTSBURGH — September 6, 2023 — Sopheon, the InnovationOps software company, announced that its customers have won the Outstanding Corporate Innovator (OCI) Award for three consecutive years. These elite global corporations are recognized by the Product Development & Management Association (PDMA) for their innovation success.

    pdma-oci-logo-minIn its 36th year, the OCI Award is the only global innovation award that recognizes sustained and quantifiable business results from new products and services. The PDMA is a global community of professionals whose skills, expertise and experience power the most recognized and respected innovative companies in the world. The founding principle is that successful commercialization of products and innovation requires efficient cross-organizational processes from concept through end-of-life exit.

    “Sopheon is proud to work alongside many of the most innovative companies in the world,” said Greg Coticchia, CEO of Sopheon. “People often associate the word ‘innovation’ with young, start-up companies. But innovation is everywhere. A glance at the most successful long-term enterprises reveals innovation at every turn. Great companies are constantly redefining, reimagining and reinventing. The most recent winners of the Corporate Innovator Award are outstanding examples of companies that combine great vision and strategy with a world-class innovation management system.”

    Sopheon’s software offerings support InnovationOps thinking and principles that help organizations with managing discovery, product management, project management, portfolio management and governance. Sopheon enables a perfect combination of creativity and structure that allows companies to respond to market needs in real time.

    To experience the power of Sopheon’s InnovationOps software, visit Accolade®, Acclaim™ Ideas, Acclaim™ Projects and Acclaim™ Products.

    About Sopheon
    Sopheon (LON:SPE) empowers organizations to change the world while achieving exceptional long-term revenue growth and profitability. By operationalizing the entire innovation life cycle, Accolade® and Acclaim™ software and expertise enable innovation, product and project professionals to accomplish the full range of InnovationOps tasks to drive innovation at scale. Sopheon’s solutions have been implemented in over 50 countries by hundreds of blue-chip customers, including the three most recent winners of the PDMA’s Outstanding Corporate Innovator Award. Sopheon is listed on the AIM Market of the London Stock Exchange.

    Accolade® and Acclaim™ are trademarks of Sopheon plc.

    www.sopheon.com/about/press-releases/...
  5. Tritace 12 september 2023 16:55

    • Tritace

      Lid sinds: 21 jan 2022

      Laatste bezoek: 31 jan 2025

    • Aanbevelingen

      Ontvangen: 16

      Gegeven: 14

    •    Aantal posts: 70

    Sopheon sets new standard for InnovationOps
    Steady march of quarterly enhancements positions Accolade as leading choice for innovation and product professionals

    PITTSBURGH, Sept. 12, 2023 - Sopheon, the InnovationOps software company, announced the launch of Accolade 16.0, featuring improved collaboration capabilities, enhanced scenario planning and easier financial management through an expanded integration with Acclaim Projects. Accolade strengthens innovation and governance processes, and helps companies improve time-to-value.

    The release of Accolade 16.0 reflects Sopheon’s recognition of the growing industry adoption of InnovationOps, a holistic framework for operationalizing innovation from incremental to breakthrough across all areas of the company. Companies that embrace InnovationOps can effectively scale innovation for consistent and profitable growth. Accolade 16.0 highlights include:

    Expanded Acclaim Projects integration, which results in improved cost management. Managers can track the percentage of expenses that can be capitalized for better financial management. Additionally, project, schedule and financial health scores provide deeper insights into the status of innovation projects.
    Enhancements to scenario planning and prioritization that make it easier than ever to find and add any project to the Portfolio Planner. An improved workflow leads to greater efficiencies throughout the innovation process.
    Improved collaboration simplifies the process of connecting communication channels and enhances collaborative editing.
    New user interface simplifies resource and scenario planning. Accolade 16.0 enhances the look and feel of the interface for improvements when viewing available project resources.
    “In this version of Accolade, Sopheon has completely reimagined resource and capacity planning,” said Mike Bauer, chief product officer of Sopheon. “In addition to resulting in better product and portfolio decisions, these improvements help keep innovation programs heading in the proper strategic direction. Over the past year, Sopheon has made enormous strides in Accolade’s capabilities. Our commitment to regular quarterly updates is designed to ensure that Accolade continues to set the industry standard for enterprise innovation management.”

    Accolade is the industry’s most complete InnovationOps tool for managing strategy, governance and portfolios. It connects entire organizations and empowers product and innovation teams to be strategic and agile when responding to marketplace change and when delivering new products. The full transparency provided by Accolade makes it possible for companies to oversee governance, portfolio and strategy at an executive and leadership level, as well as manage products and projects at a team member level.

    To experience the power of Sopheon’s InnovationOps software, visit Accolade®, Acclaim™ Ideas, Acclaim™ Projects and Acclaim™ Products

    www.sopheon.com/about/press-releases/...
  7. Tritace 13 september 2023 08:56

    • Tritace

      Lid sinds: 21 jan 2022

      Laatste bezoek: 31 jan 2025

    • Aanbevelingen

      Ontvangen: 16

      Gegeven: 14

    •    Aantal posts: 70

    quote:

    Spectator schreef op 10 september 2023 12:56:

    Wie begrijpt wat er aan de hand is? Het lijkt dat het Sopheon voor de wind gaat. Toch loopt de waarde van het aandeel sinds 2018 alleen maar achteruit.
    Mogelijk dat beleggers eerst klinkende cijfers in omzet en winst willen zien.
    Nauwelijks handel in het aandeel helpt natuurlijk ook niet.
    Ik verwacht dat de omzet vanaf 2024 e.v. substantieel gaat stijgen
  8. [verwijderd] 13 september 2023 12:09

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    nog ff doorbijten, verwacht eind dit jaar, ruim 10 pond. komen ook nog 2 grote orders van 2 militaire bestaande klanten. volgens het verslag van 24 augustus 2023.
    volgend jaar kon het welis heel intresant gaan worden met soof. ligt er ook aan wat er allemaal in de wereld gaat gebeuren. time will tell.
  12. Arie de Beuker 15 september 2023 07:23

    • Arie de Beuker

      Lid sinds: 17 mrt 2005

      Laatste bezoek: 31 jan 2025

    • Aanbevelingen

      Ontvangen: 212

      Gegeven: 545

    •    Aantal posts: 1.436

    Volgens technische analyse zeggen ze verkopen maar de gezien de huidige ontwikkelingen, dus fundamenteel zou Sopheon best eens een mooie koopkans kunnen zijn.

    Gr
    Arie de Beuker
  13. [verwijderd] 15 september 2023 10:08

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    investing zegt verkopen , terwijl finn cap een target price van 12,50 pond blijft volhouden. je moet je eigen gevoel volgen, ik zit vol in soof. heb er genoeg koop niks meer bij, maar dit is wel een leuk koop prijsje. vorige maand heeft veradace partners nog voor rond de 2 miljoen euro aandelen gekocht. zouden ze dat in de blind hebben gedaan? ik denk zelf van niet. valt wel op dat de laatste tijd met een klein aantal de koers naar beneden wordt gedrukt. dat gebeurde ook in ik dacht in 2018, binnen een jaar stond de koers ruim op 14 pond.
    wat er ook gebeurt, ik hou ze stug vast. goed weekend all.
  14. Spectator 18 september 2023 19:21

    • Spectator

      Lid sinds: 21 jul 2022

      Laatste bezoek: 16 dec 2024

    • Aanbevelingen

      Ontvangen: 5

      Gegeven: 0

    •    Aantal posts: 19

    Ook ik zit flink in Soof, Hunkey. Hopelijk kunnen we Soofs goede resultaten een keer terugzien in de koers.
    Die kleine koersdrukkende dagelijkse aankopen blijf ik vreemd vinden.
14 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 6.997
AB InBev 2 5.479
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.111
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.445
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.622
Aedifica 3 900
Aegon 3.258 322.599
AFC Ajax 537 7.084
Affimed NV 2 6.287
ageas 5.844 109.883
Agfa-Gevaert 14 2.046
Ahold 3.538 74.287
Air France - KLM 1.025 34.971
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.017
Alfen 16 24.222
Allfunds Group 4 1.467
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 403
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.806
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.834 242.585
AMG 971 132.995
AMS 3 73
Amsterdam Commodities 305 6.685
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 481
Antonov 22.632 153.605
Aperam 92 14.885
Apollo Alternative Assets 1 17
Apple 5 375
Arcadis 252 8.731
Arcelor Mittal 2.033 320.441
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.278
Aroundtown SA 1 219
Arrowhead Research 5 9.715
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.060
ASML 1.766 105.276
ASR Nederland 21 4.450
ATAI Life Sciences 1 7
Atenor Group 1 465
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.579
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.383